Ofloxacin ophthalmic (ofloxacin) NDC 59390-140

NDC codes

FDA NDC Directory

Product NDC (as listed)59390-140Labeler and product segments. Claims need a package NDC.

Product NDC at billing width59390-0140Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
59390-140-05	59390014005	5 mL in 1 BOTTLE, DROPPER (59390-140-05)Marketed from May 31, 2013

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Ofloxacin ophthalmic
Generic name (nonproprietary): ofloxacin
Active ingredients: Ofloxacin — 3 mg/mL
Dosage form: Solution
Route: Ophthalmic
Labeler: Altaire Pharmaceuticals Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 202692
Marketing start: May 31, 2013
Listing expires: Dec 31, 2026
Other FDA classes: Quinolones (Chemical structure)
Identifiers: Product ID 59390-140_28125c1a-d1b0-4763-9b5e-07b4cfc2d889SPL ID 28125c1a-d1b0-4763-9b5e-07b4cfc2d889SPL set ID fe564e33-8f5d-4b57-87a9-7afae02eaf97RxCUI 312075UNII A4P49JAZ9H
Pharmacologic class: Quinolone Antimicrobial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N459390014005 followed by a unit qualifier and the quantity

Package 59390-0140-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 28, 2022.

Indications (excerpt from the label)

INDICATIONS AND USAGE Ofloxacin ophthalmic solution, USP is indicated for the treatment of infections caused by susceptible strains of the following bacteria in the conditions listed below: CONJUNCTIVITIS: Gram-positive bacteria: Gram-negative bacteria: Staphylococcus aureus Staphylococcus epidermidis Streptococcus pneumonia Enterobacter cloacae Haemophilus influenza Proteus mirabilis Pseudomonas aeruginosa CORNEAL ULCERS: Gram-positive bacteria: Gram-negative bacteria: Staphylococcus aureus Staphylococcus epidermidis Streptococcus pneumoniae Pseudomonas aeruginosa Serratia marcascens ' Anaerobic species: Propionibacterium acnes * Efficacy for this organism was studied in fewer than 10 infec…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)